首页|补肾安胎冲剂对人胎盘微血管内皮细胞VEGF/PI3K/Akt信号通路表达的影响

补肾安胎冲剂对人胎盘微血管内皮细胞VEGF/PI3K/Akt信号通路表达的影响

扫码查看
目的 基于VEGFR-2沉默探讨补肾安胎冲剂(后文简称BSAT)对人胎盘微血管内皮细胞(human placental microvascular endothelial cells,HPMVECs)的影响,通过血管内皮生长因子(vascular endothelial growth factor,VEGF)/磷脂酰肌醇 3 激酶(phosphoinositide 3-kinase,PI3K)/丝苏氨酸蛋白激酶(protein kinase B,Akt)通路探索其治疗复发性流产(recurrent spontaneous abortion,RSA)的作用机制。方法 在体外构建人胎盘微血管内皮细胞,随后采用转染小干扰RNA(siRNA)技术沉默VEGFR-2基因表达,并给予补肾安胎冲剂含药血清或空白血清干预,将人胎盘微血管内皮细胞分为空白血清组(PBS+空白血清)、siRNA空白血清组(PBS+VEGFR-2 siRNA+空白血清)、siRNA NC 空白血清组(PBS+NC siRNA+空白血清)、siRNA 药物血清组(PBS+VEGFR-2 siRNA+BSAT含药血清)、药物血清组(PBS+BSAT含药血清)予对应处理,实时荧光定量PCR、免疫荧光法及Western blot分别检测VEGF、VEGFR-2、PI3K、Akt mRNA及蛋白表达,观察在VEGFR-2基因沉默时,补肾安胎冲剂是否能通过PI3K/Akt通路介导血管新生。结果 空白血清组和siRNA NC空白血清组相比,VEGF、VEGFR-2、PI3K、Akt mRNA及蛋白无明显差异(P>0。05);药物血清组细胞VEGF、VEGFR-2、PI3K、Akt mRNA及蛋白的表达明显高于空白血清组(P<0。05)。与空白血清组相比,siRNA空白血清组VEGF、VEGFR-2、PI3K、Akt mRNA及蛋白的表达明显下降(P<0。01)。siRNA药物血清组与siRNA空白血清组相比,VEGF、VEGFR-2、PI3K、Akt有明显上升(P<0。01),补肾安胎冲剂能显著提高VEGF/PI3K/Akt的低表达。结论 补肾安胎冲剂通过激活HPMVECs中VEGFR-2,靶向上调PI3K/Akt表达,介导血管新生,促进母胎界面血管重构,从而对RSA发挥治疗作用。
The effects of Bushen Antai Granules on the expression of VEGF/PI3K/Akt signaling pathway in human placental microvascular endothelial cells
Objective To investigate the effect of Bushen Antai(BSAT)Granules on human placental microvascular endothelial cells(HPMVECs)based on VEGFR-2 silencing,and to explore its mechanism of action in treating recurrent spontaneous abortion(RSA)through the vascular endothelial growth factor(VEGF)/phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt)pathway.Methods Human placental microvascular endothelial cells were constructed in vitro,and then the expression of VEGFR-2 gene was silenced by transfection of small interfering RNA(siRNA)technology.The cells were intervened with Bushen Antai Granules drug containing serum or blank serum.The human placental micro-vascular endothelial cells were divided into blank serum group(PBS+blank serum),siRNA blank serum group(PBS+VEGFR-2 siRNA+blank serum),siRNA NC blank serum group(PBS+NC siRNA+blank serum),siRNA drug serum(PBS+VEGFR-2 siRNA+BSAT drug containing serum),and drug serum group(PBS+BSAT drug containing serum)for corresponding treatment.VEGF and VEGFR-2 were detected by real-time fluorescence quantitative PCR,immunofluorescence,and Western blotting.Observe the expression of PI3K,Akt mRNA and protein,and observe whether Bushen Antai Granules can mediate angiogenesis through the PI3K/Akt pathway when VEGFR-2 gene is silenced.Results There were no significant differences in VEGF,VEGFR-2,PI3K,Akt mRNA and protein between the blank serum group and the siRNA NC blank serum group(P>0.05);The expression of VEGF,VEGFR-2,PI3K,Akt mRNA and protein in the drug serum group was significantly higher than that in the blank serum group(P<0.05).Compared with the blank serum group,the siRNA blank serum group showed a significant decrease in the expression of VEGF,VEGFR-2,PI3K,Akt mRNA and protein(P<0.01).Compared with the siRNA blank serum group,the siRNA drug serum group showed a significant increase in VEGF,VEGFR-2,PI3K,and Akt(P<0.01),and the Bushen Antai Granules could significantly increase the low expression of VEGF/PI3K/Akt.Conclusion Bushen Antai Granules activate VEGFR-2 in HPMVECs,target upregulation of PI3 K/Akt expression,mediate angiogenesis,promote maternal fetal interface vascular remodeling,and thus exert therapeutic effects on RSA.

Bushen Antai Granulesrecurrent miscarriage abortionplacental microvascular endothelial cellsPI3K/Akt signaling pathwayVEGF

李元琪、李伟莉、储继军、余欣慧、吴俊、陆莎莎

展开 >

230000 合肥,安徽中医药大学第一附属医院妇产科

蒙城县中医院妇科

补肾安胎冲剂 复发性流产 胎盘微血管内皮细胞 磷脂酰肌醇3激酶/丝苏氨酸蛋白激酶信号通路 血管内皮生长因子

2024

环球中医药
中华国际医学交流基金会

环球中医药

CSTPCD
影响因子:1.553
ISSN:1674-1749
年,卷(期):2024.17(12)